Bon Natural Life Ltd (BON) stock

BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30

Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 23, 2026Score 0/30

$1.10−0.03 (-2.65%)

Close on Nov 13, 2026Market cap $8.94MP/E –Yield –

Bon Natural Life gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 20.8%, against 29.8% the year before. The highest annual figure on record is 32.2% in fiscal 2019.

Period	Period end	Value	Change (pts)
FY2025	Sep 30, 2025	20.8%	−9.0
FY2024	Sep 30, 2024	29.8%	−0.1
FY2023	Sep 30, 2023	29.9%	−1.6
FY2022	Sep 30, 2022	31.5%	+3.6
FY2021	Sep 30, 2021	27.9%	−0.7
FY2020	Sep 30, 2020	28.6%	−3.7
FY2019	Sep 30, 2019	32.2%	–

Parsed from the XBRL in Bon Natural Life's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-25 reverse split on May 19, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BON.

Revenue growth-21.7% · median 8.5%

Gross margin20.8% · median 61.1%

Operating margin-8.7% · median -21.9%

Net margin-10.7% · median -14.0%

Advertisement
300 × 250

See a number that looks wrong?